Learn More
Abcam SD 169, ATP-competitive p38alpha MAPK inhibitor, 50MG
Supplier: Abcam AB12083650MG
MW 160.17 Da, Purity >99%. Potent, selective and ATP-competitive p38α MAPK inhibitor (IC₅₀ values are 3.2 and 122 nM for α and β, respectively). Orally active. Promotes axonal regeneration in vivo.
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.